SWE
Toggle navigation
English
Svenska
About Us
The Company
Board & Management
Scientific Advisory Board
Scientific Publications
Events & Mediawatch
Careers
Contact Us
Expanded Access Policy
Diabetes
Products
Manufacturing
Clinical Trials
Investors
Investor Relations
CEO Comments
Corporate Governance
Press Releases
Financial Reports
Financial Calendar
Rights Issue
Skip Navigation Links
Home
»
Subscribe
Subscription Form
Language preference:
*
English
Swedish
Subscribe to:
*
Reports
Press releases
* = required field
Press Releases and Financial Reports are distributed by
Cision
. After submitting this form, you will receive an email from Cision asking you to confirm your subscription. To unsubscribe or change subscription preferences, please use the link provided in the confirmation email you will receive after confirming your subscription. Please save the link for future use.
Posts published under
Events & Mediawatch
can no longer be subscribed to via email. Please follow us on Twitter/LinkedIn to receive the latest posts.
Follow Us
Press Releases
April 25, 2025
Diamyd Medical’s pivotal Phase 3 Type 1 Diabetes trial clears second-to-last safety review ahead...
25 april 2025
Diamyd Medicals fas 3-studie i typ 1-diabetes har passerat den näst sista säkerhetsgranskningen...
Financial Reports
April 9, 2025
Quarterly Report 2 24/25
9 april 2025
Delårsrapport 2 24/25
©
Privacy Policy
|
Cookie Policy
|
Expanded Access Policy
Share This Page
select
Facebook
Twitter
LinkedIn
Google Plus
Pinterest
Tumblr
StumbleUpon
Blogger
MySpace
Digg
Reddit
Email
GAD PRODUCTS
Order GAD for preclinical research